ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 348121 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 348121; 2) Community: the network communities that were significantly associated with the response to NSC 348121; 3) Molecule: the relationships between components within communities and NSC 348121; 4) MDR: the compounds that were significantly associated with the NSC 348121.

NSC Compound Enrichment Correlation
NSC 715648 Null 0.0102077332082017 -0.1983761
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0102077332082017 -0.12826922
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0102962192514438 0.047121799
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0102962192514438 -0.15991438
NSC 716765 Null 0.0102962192514438 -0.019027028
NSC 88054 Null 0.0102962192514438 0.22966569
NSC 46683 Null 0.0102962192514439 0.10956299
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.0102962192514439 0.49703631
NSC 630602 1-Piperidinecarboxylic acid, 4-oxo-3,5-bis(phenyl- methylene)-, ethyl ester 0.0102962192514439 0.30485429
NSC 680510 1,8-Naphthyridin-3-amine, 2,7-dichloro-5-methyl- 0.0102962192514439 0.37411966
Total:64  Current:14    [First] [Prev] [Next] [Last]